344 related articles for article (PubMed ID: 31621605)
1. Altered brain structural topological properties in Parkinson's disease with levodopa-induced dyskinesias.
Wang L; Wang M; Si Q; Yuan Y; Ma K; Gan C; Zhang K
Parkinsonism Relat Disord; 2019 Oct; 67():36-41. PubMed ID: 31621605
[TBL] [Abstract][Full Text] [Related]
2. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
[TBL] [Abstract][Full Text] [Related]
3. Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson's disease.
Herz DM; Haagensen BN; Nielsen SH; Madsen KH; Løkkegaard A; Siebner HR
Mov Disord; 2016 Apr; 31(4):521-9. PubMed ID: 26954295
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.
Politis M; Wu K; Loane C; Brooks DJ; Kiferle L; Turkheimer FE; Bain P; Molloy S; Piccini P
J Clin Invest; 2014 Mar; 124(3):1340-9. PubMed ID: 24531549
[TBL] [Abstract][Full Text] [Related]
5. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.
Cerasa A; Koch G; Donzuso G; Mangone G; Morelli M; Brusa L; Stampanoni Bassi M; Ponzo V; Picazio S; Passamonti L; Salsone M; Augimeri A; Caltagirone C; Quattrone A
Brain; 2015 Feb; 138(Pt 2):414-27. PubMed ID: 25414038
[TBL] [Abstract][Full Text] [Related]
6. Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study.
Cerasa A; Messina D; Pugliese P; Morelli M; Lanza P; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
Mov Disord; 2011 Apr; 26(5):807-12. PubMed ID: 21384430
[TBL] [Abstract][Full Text] [Related]
7. White matter alterations in Parkinson's disease with levodopa-induced dyskinesia.
Ogawa T; Hatano T; Kamagata K; Andica C; Takeshige-Amano H; Uchida W; Saito Y; Shimo Y; Oyama G; Umemura A; Iwamuro H; Ito M; Hori M; Aoki S; Hattori N
Parkinsonism Relat Disord; 2021 Sep; 90():8-14. PubMed ID: 34325387
[TBL] [Abstract][Full Text] [Related]
8. PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.
Pagano G; Yousaf T; Politis M
Curr Neurol Neurosci Rep; 2017 Oct; 17(11):90. PubMed ID: 28975571
[TBL] [Abstract][Full Text] [Related]
9. The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias.
Cerasa A; Donzuso G; Morelli M; Mangone G; Salsone M; Passamonti L; Augimeri A; Arabia G; Quattrone A
Mov Disord; 2015 Dec; 30(14):1912-20. PubMed ID: 26275050
[TBL] [Abstract][Full Text] [Related]
10. Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.
Cerasa A; Pugliese P; Messina D; Morelli M; Gioia MC; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
Mov Disord; 2012 Mar; 27(3):364-71. PubMed ID: 22076870
[TBL] [Abstract][Full Text] [Related]
11. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G
J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853
[TBL] [Abstract][Full Text] [Related]
12. Changes of brain structural network connection in Parkinson's disease patients with mild cognitive dysfunction: a study based on diffusion tensor imaging.
Wang W; Mei M; Gao Y; Huang B; Qiu Y; Zhang Y; Wang L; Zhao J; Huang Z; Wang L; Nie K
J Neurol; 2020 Apr; 267(4):933-943. PubMed ID: 31792673
[TBL] [Abstract][Full Text] [Related]
13. Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias.
Ahmed I; Bose SK; Pavese N; Ramlackhansingh A; Turkheimer F; Hotton G; Hammers A; Brooks DJ
Brain; 2011 Apr; 134(Pt 4):979-86. PubMed ID: 21371994
[TBL] [Abstract][Full Text] [Related]
14. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias.
Piccini P; Weeks RA; Brooks DJ
Ann Neurol; 1997 Nov; 42(5):720-6. PubMed ID: 9392571
[TBL] [Abstract][Full Text] [Related]
15. Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias.
Ponzo V; Picazio S; Benussi A; Di Lorenzo F; Brusa L; Caltagirone C; Koch G
Mov Disord; 2016 May; 31(5):755-9. PubMed ID: 26861941
[TBL] [Abstract][Full Text] [Related]
16. Connectome analysis with diffusion MRI in idiopathic Parkinson's disease: Evaluation using multi-shell, multi-tissue, constrained spherical deconvolution.
Kamagata K; Zalesky A; Hatano T; Di Biase MA; El Samad O; Saiki S; Shimoji K; Kumamaru KK; Kamiya K; Hori M; Hattori N; Aoki S; Pantelis C
Neuroimage Clin; 2018; 17():518-529. PubMed ID: 29201640
[TBL] [Abstract][Full Text] [Related]
17. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
[TBL] [Abstract][Full Text] [Related]
18. Dyskinesias in Parkinson's disease: views from positron emission tomography studies.
Niccolini F; Loane C; Politis M
Eur J Neurol; 2014 May; 21(5):694-9, e39-43. PubMed ID: 24471508
[TBL] [Abstract][Full Text] [Related]
19. The acute brain response to levodopa heralds dyskinesias in Parkinson disease.
Herz DM; Haagensen BN; Christensen MS; Madsen KH; Rowe JB; Løkkegaard A; Siebner HR
Ann Neurol; 2014 Jun; 75(6):829-36. PubMed ID: 24889498
[TBL] [Abstract][Full Text] [Related]
20. Impaired topological architecture of brain structural networks in idiopathic Parkinson's disease: a DTI study.
Li C; Huang B; Zhang R; Ma Q; Yang W; Wang L; Wang L; Xu Q; Feng J; Liu L; Zhang Y; Huang R
Brain Imaging Behav; 2017 Feb; 11(1):113-128. PubMed ID: 26815739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
